{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T17:22:22Z","timestamp":1777742542736,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","issue":"5","content-domain":{"domain":["ijaaonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.ijantimicag.2013.06.020","type":"journal-article","created":{"date-parts":[[2013,8,9]],"date-time":"2013-08-09T22:47:13Z","timestamp":1376088433000},"page":"416-421","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Bactericidal synergism between daptomycin and the phage lysin Cpl-1 in a mouse model of pneumococcal bacteraemia"],"prefix":"10.1016","volume":"42","author":[{"given":"Jacques","family":"Vouillamoz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 M.","family":"Entenza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlyse","family":"Giddey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent A.","family":"Fischetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Moreillon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gr\u00e9gory","family":"Resch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2013.06.020_bib0005","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1053\/prrv.2000.0008","article-title":"Impact of bacterial pneumonias on world child health","volume":"1","author":"English","year":"2000","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.ijantimicag.2013.06.020_bib0010","series-title":"Pneumococcal disease. Epidemiology and prevention of vaccine-preventable diseases","author":"US Centers for Disease Control and Prevention","year":"2012"},{"key":"10.1016\/j.ijantimicag.2013.06.020_bib0015","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1086\/430352","article-title":"Inhibition of daptomycin by pulmonary surfactant: in vitro modeling and clinical impact","volume":"191","author":"Silverman","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2013.06.020_bib0020","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.cbpa.2009.02.031","article-title":"Daptomycin: mechanisms of action and resistance, and biosynthetic engineering","volume":"13","author":"Baltz","year":"2009","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.ijantimicag.2013.06.020_bib0025","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1128\/AAC.00943-09","article-title":"Efficacy profiles of daptomycin for treatment of invasive and noninvasive pulmonary infections with Streptococcus pneumoniae","volume":"54","author":"Henken","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2013.06.020_bib0030","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1128\/AAC.01014-06","article-title":"Prevention of brain injury by the nonbacteriolytic antibiotic daptomycin in experimental pneumococcal meningitis","volume":"51","author":"Grandgirard","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2013.06.020_bib0035","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1128\/AAC.48.10.3928-3933.2004","article-title":"Daptomycin is highly efficacious against penicillin-resistant and penicillin- and quinolone-resistant pneumococci in experimental meningitis","volume":"48","author":"Cottagnoud","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2013.06.020_bib0040","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1164\/rccm.200311-1578OC","article-title":"Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia","volume":"170","author":"Baddour","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2013.06.020_bib0045","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s10096-005-0019-5","article-title":"Optimal antibiotic treatment in severe pneumococcal pneumonia\u2013time for real answers","volume":"24","author":"Waterer","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2013.06.020_bib0050","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1128\/AAC.00487-10","article-title":"Daptomycin\u2013oxacillin combinations in treatment of experimental endocarditis caused by daptomycin-nonsusceptible strains of methicillin-resistant Staphylococcus aureus with evolving oxacillin susceptibility (the \u2018seesaw effect\u2019)","volume":"54","author":"Yang","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2013.06.020_bib0055","doi-asserted-by":"crossref","first-page":"6064","DOI":"10.1128\/AAC.01760-12","article-title":"Combination therapy with ampicillin and daptomycin for treatment of Enterococcus faecalis endocarditis","volume":"56","author":"Sierra-Hoffman","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl. 1","key":"10.1016\/j.ijantimicag.2013.06.020_bib0060","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.ijantimicag.2003.08.004","article-title":"The epidemiology of antibiotic resistance in Streptococcus pneumoniae and the clinical relevance of resistance to cephalosporins, macrolides and quinolones","volume":"22","author":"Pallares","year":"2003","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2013.06.020_bib0065","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1007\/s10096-005-0059-x","article-title":"Drug-resistant pneumococcal pneumonia: clinical relevance and approach to management","volume":"24","author":"Fuller","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2013.06.020_bib0070","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1128\/MMBR.56.3.430-481.1992","article-title":"Bacteriophage lysis: mechanism and regulation","volume":"56","author":"Young","year":"1992","journal-title":"Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2013.06.020_bib0075","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.mib.2008.09.012","article-title":"Bacteriophage lysins as effective antibacterials","volume":"11","author":"Fischetti","year":"2008","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.ijantimicag.2013.06.020_bib0080","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1128\/AAC.00890-10","article-title":"A novel chimeric lysin shows superiority to mupirocin for skin decolonization of methicillin-resistant and -sensitive Staphylococcus aureus strains","volume":"55","author":"Pastagia","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2013.06.020_bib0085","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1126\/science.1066869","article-title":"Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase","volume":"294","author":"Loeffler","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.ijantimicag.2013.06.020_bib0090","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/nature01026","article-title":"A bacteriolytic agent that detects and kills Bacillus anthracis","volume":"418","author":"Schuch","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ijantimicag.2013.06.020_bib0095","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1086\/521305","article-title":"Efficient elimination of multidrug-resistant Staphylococcus aureus by cloned lysin derived from bacteriophage (MR11","volume":"196","author":"Rashel","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2013.06.020_bib0100","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1128\/JVI.61.8.2573-2580.1987","article-title":"Cloning, purification, and biochemical characterization of the pneumococcal bacteriophage Cp-1 lysin","volume":"61","author":"Garc\u00eda","year":"1987","journal-title":"J Virol"},{"key":"10.1016\/j.ijantimicag.2013.06.020_bib0105","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1128\/JVI.40.2.551-559.1981","article-title":"Isolation and characterization of a new bacteriophage, Cp-1, infecting Streptococcus pneumoniae","volume":"40","author":"Ronda","year":"1981","journal-title":"J Virol"},{"key":"10.1016\/j.ijantimicag.2013.06.020_bib0110","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1093\/jac\/dkg485","article-title":"Phage lytic enzymes as therapy for antibiotic-resistant Streptococcus pneumoniae infection in a murine sepsis model","volume":"52","author":"Jado","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2013.06.020_bib0115","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1128\/IAI.71.11.6199-6204.2003","article-title":"Phage lytic enzyme Cpl-1 as a novel antimicrobial for pneumococcal bacteremia","volume":"71","author":"Loeffler","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.ijantimicag.2013.06.020_bib0120","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/CCM.0b013e31819586a6","article-title":"Systemic use of the endolysin Cpl-1 rescues mice with fatal pneumococcal pneumonia","volume":"37","author":"Witzenrath","year":"2009","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2013.06.020_bib0125","doi-asserted-by":"crossref","first-page":"4789","DOI":"10.1128\/AAC.49.11.4789-4792.2005","article-title":"Therapeutic effects of bacteriophage Cpl-1 lysin against Streptococcus pneumoniae endocarditis in rats","volume":"49","author":"Entenza","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2013.06.020_bib0130","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1086\/587942","article-title":"Phage lytic enzyme Cpl-1 for antibacterial therapy in experimental pneumococcal meningitis","volume":"197","author":"Grandgirard","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2013.06.020_bib0135","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1128\/AAC.49.3.1225-1228.2005","article-title":"Synergistic killing of Streptococcus pneumoniae with the bacteriophage lytic enzyme Cpl-1 and penicillin or gentamicin depends on the level of penicillin resistance","volume":"49","author":"Djurkovic","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2013.06.020_bib0140","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1128\/JB.01148-06","article-title":"Genome sequence of Avery's virulent serotype 2 strain D39 of Streptococcus pneumoniae and comparison with that of unencapsulated laboratory strain R6","volume":"189","author":"Lanie","year":"2007","journal-title":"J Bacteriol"},{"key":"10.1016\/j.ijantimicag.2013.06.020_bib0145","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/s10096-003-1016-1","article-title":"Meropenem prevents levofloxacin-induced resistance in penicillin-resistant pneumococci and acts synergistically with levofloxacin in experimental meningitis","volume":"22","author":"Cottagnoud","year":"2003","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2013.06.020_bib0150","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1128\/AAC.47.1.375-377.2003","article-title":"Synergistic lethal effect of a combination of phage lytic enzymes with different activities on penicillin-sensitive and -resistant Streptococcus pneumoniae strains","volume":"47","author":"Loeffler","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2013.06.020_bib0155","unstructured":"Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. 9th ed. Document M07-A9. Wayne, PA: CLSI; 2012."},{"key":"10.1016\/j.ijantimicag.2013.06.020_bib0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkg301","article-title":"antagonism, and what the chequerboard puts between them","volume":"52","author":"Synergy","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2013.06.020_bib0165","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.1128\/IAI.00290-09","article-title":"Streptococcus pneumoniae autolysis prevents phagocytosis and production of phagocyte-activating cytokines","volume":"77","author":"Martner","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.ijantimicag.2013.06.020_bib0170","first-page":"35","article-title":"How to calculate sample size in animal studies?","volume":"1","author":"Shah","year":"2011","journal-title":"Natl J Physiol Pharm Pharmacol"},{"key":"10.1016\/j.ijantimicag.2013.06.020_bib0175","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1055\/s-2005-925523","article-title":"Streptococcus pneumoniae: epidemiology, risk factors, and clinical features","volume":"26","author":"Ortqvist","year":"2005","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2013.06.020_bib0180","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1086\/315760","article-title":"Prospective study of prognostic factors in community-acquired bacteremic pneumococcal disease in 5 countries","volume":"182","author":"Kalin","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2013.06.020_bib0185","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/jac\/dkh546","article-title":"Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections","volume":"55","author":"Steenbergen","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2013.06.020_bib0190","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.jhin.2007.01.002","article-title":"Daptomycin-resistant Enterococcus faecium in a patient with no prior exposure to daptomycin","volume":"65","author":"Fraher","year":"2007","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ijantimicag.2013.06.020_bib0195","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/00365540600786465","article-title":"Infective endocarditis caused by daptomycin-resistant Enterococcus faecalis: a case report","volume":"39","author":"Kanafani","year":"2007","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2013.06.020_bib0200","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1128\/AAC.00223-11","article-title":"In vitro cross-resistance to daptomycin and host defense cationic antimicrobial peptides in clinical methicillin-resistant Staphylococcus aureus isolates","volume":"55","author":"Mishra","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2013.06.020_bib0205","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1155\/2010\/618953","article-title":"Methicillin-resistant Staphylococcus aureus endocarditis and de novo development of daptomycin resistance during therapy","volume":"21","author":"Twele","year":"2010","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"10.1016\/j.ijantimicag.2013.06.020_bib0210","doi-asserted-by":"crossref","first-page":"4326","DOI":"10.1128\/AAC.01819-10","article-title":"Reduction in membrane phosphatidylglycerol content leads to daptomycin resistance in Bacillus subtilis","volume":"55","author":"Hachmann","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2013.06.020_bib0215","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ijantimicag.2009.12.022","article-title":"In vitro prevention of the emergence of daptomycin resistance in Staphylococcus aureus and enterococci following combination with amoxicillin\/clavulanic acid or ampicillin","volume":"35","author":"Entenza","year":"2010","journal-title":"Int J Antimicrob Agents"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857913002586?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857913002586?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T19:30:30Z","timestamp":1596310230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857913002586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0924857913002586"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2013.06.020","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bactericidal synergism between daptomycin and the phage lysin Cpl-1 in a mouse model of pneumococcal bacteraemia","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2013.06.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}